By Mary-Katherine Stinson
Lexington, Ky., May 8 – China Resources Pharmaceutical Group Ltd. said its wholly owned subsidiary, China Resources Pharmaceutical Commercial Group Co. Ltd., issued RMB 2 billion of 3.09% three-year bonds, according to a notice.
This is the company’s first tranche of corporate bonds for 2023.
Proceeds will be used to repay debt.
The investment holding company is based in Hong Kong.
| Issuer: | China Resources Pharmaceutical Commercial Group Co. Ltd.
|
| Amount: | RMB 2 billion
|
| Issue: | Corporate bonds, 2023 first tranche
|
| Tenor: | Three years
|
| Coupon: | 3.09%
|
| Announcement date: | May 8
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
